Does a same-price-at-every-dose promise hold?

Mostly, and the exclusions are where to look. 83 of the 412 companies published here promise one price at every dose; 1 publish an exclusion that takes part of it back, and 47 say plainly that the price follows the dose instead.

Who promises one price at every dose?

83 of 412: Eden, Henry Meds, CoreAge Rx, Gala Health, Care Bare Rx, Gimme Care, Cora Health, RxPros, Alan Health, Ivy Rx, Amble, TrimRx, HealthiCare, Enhance MD, MyFastRx, MEDVi, Willow, Fella Health, NewSelf, Embody, Trimi, He & She MD, Livv, ReadyRx, Bodybuilding Health+, MEDGm, altRx, Trinity Meds, Yucca Health, SnagRx, Lttl, Pallas Health, TRT Nation, PlexusDx, Loop Health, Telezen MD, Raeliva, Medro, REMEVi, Vyora Wellness, FormBlends, iThriveMD, PrescribedRX, Leanmeds, RxION Health, Rylo Health, Kin Meds, Alternate Health Club, CLYR Health, Coivas, Elevated Health, Factor Health MD, Kongo, Mondae, Ozari Health, RxSaludable, Wellorithm, Genesis Health, Näky, Vytora Health, Open Water Rx, FitFlow, Kina, The Edit, Trellis Vitality, Bodi Envi, DrBrainRx, Lovely Meds, NuuVim, Obu Health, Rewinding RX, Edessa, Nolu, Roboclinic, Candor Rx, Carocare Wellness, Center for Medical Weight Loss, Mint Med, NexLife, Novi, Revel RX, Rx Platform, and Goal MD. The wording varies and the commitment does too, so here is each one's own sentence rather than our summary of it.

CoreAge Rx goes further than the phrase usually implies, and we say so as a site it pays a commission to: Same price at every dose, and CoreAge goes further than most: whatever price you lock in at checkout stays the same for all future months, regardless of dose increases. That is a price lock rather than a dose policy, and it is the strongest version of this claim in the roster.

What do the exclusions say?

1 of the 83 promises carry a published condition, and both are worth reading in full because they narrow the claim in different directions.

Eden excludes one thing: Eden publishes a Same Price at Every Dose policy covering dosage adjustments, excluding new-member promotions. That is a narrow, sensible carve-out: the promise covers the dose and not the discount that got you in.

Amble is the one that changes what the promise is. The badge above its plan table says Same price, every dose. The disclosure at the foot of the same page reads: The claim 'same price at every dose' is subject to the following: Pricing may change at any time due to supply or market conditions at the discretion of [Amble]. Any 'same price at every dose' promotion expires within 24 hours of any price updates. And separately: Introductory or promotional pricing, including 'first month' offers, are not governed by the 'same price per dose' policy and only apply to full-price products as listed on the website.

Read those two sentences together and the promise is a promotion with a 24-hour life, revocable at the company's discretion, that does not cover the introductory price most new patients start on. It is disclosed in full, on the same page, and it is not the commitment the badge above it describes.

What does a dose ladder cost at the top?

Several times the entry figure. 47 companies here say the price follows the dose, and the ones that publish the whole table are doing a reader more good than the ones that promise flatly and qualify it later. What that costs at the top:

Mochi Health publishes the cleanest version of a climbing ladder, dose by dose: Priced per dose, and published: 0.22 mg $60, 0.44 mg $70, 0.88 mg $82, 1.5 mg $92, 2.21 mg $96, 2.67 mg $99, 4.5 mg $151, 6.48 mg $189. Coby Health does it by month instead, which is the same information arranged the way a patient actually meets it: Month 1 (0.25mg): $159 · Month 2 (0.50mg): $199 · Month 3 (1.0mg): $229 · Month 4 (1.7mg): $249 · Month 5+ (2.4mg): $249. The advertised figure on both is the first rung.

The version to watch for is the third one: a price that moves with the dose and no table at all. Care Bare Rx's own words are Price varies by dose and medication prescribed, in their own words, and no tier table is published. Trava puts a warning under its dose selector, Your price will change if you need to adjust your dose for a better experience., and publishes no figure for any dose above the first. Breeze Meds footnotes its plan screen with *Prices are based on lowest dosage rates. Higher dosages may reflect a higher rate. Please review product descriptions for dosage pricing. In each case the advertised number is a floor, and nothing on the site says how far above it the ceiling is.

Can one company do both at once?

7 companies do, and it is the sort of thing a skim misses. HealthiCare states Your medication price does not increase with your prescribed dose beside the itemized receipt for its compounded plans and, on the same site, prices the Wegovy tablet differently: Wegovy tablets are priced per dose tier.

Both sentences are true of their own products, so this is not a contradiction so much as a scope a reader has to notice. Its own tiers run $268.68 for wegovy tablets, doses 1 and 2 (1.5 mg and 4 mg) and $448.79 for wegovy tablets, maintenance doses (9 mg and 25 mg), which is the part the flat-price sentence, read alone, would have led you to rule out.

Where is the promise actually published?

0 records contain a promise originally read behind an intake. These are dated observations; a company may since have moved the same promise onto a public page. Gala Health's version is Same Price. All Dosage Levels. One price. Forever., and none of it appears on any public Gala page in the original research. TrimRx also carried its promise on an August 2026 order summary. Its current public home page now promises a steady price as the prescribed dose changes, so that older access criticism no longer applies to TrimRx.

That placement is why the checkout shows what the home page doesn't. An intake-only promise is difficult to compare across browser tabs. TrimRx now publishes its dose-price promise publicly, although its complete current renewal ladder remains unverified.

So does the promise hold?

For most of the companies making it, yes. 82 of the 83 promises in this roster are written flat, with no published condition on them, and one of them locks your price at checkout for good.

The promise fails in three specific ways, and they are the three to check before you believe one. It fails where an exclusion revokes it: Amble's expires 24 hours after any price update and does not cover the introductory rate. It fails by scope, where a company promises flatly on one product and prices another by tier, which is HealthiCare. A promise disclosed only after an intake is harder to compare. That concern was recorded for Gala and TrimRx in August 2026, but TrimRx now makes its dose-price claim publicly.

What it never means is that you are getting the cheapest treatment. The dearest flat price in this set is $1,399 at Eden, which is not a bargain merely because it does not move, and the entry rung of a ladder is often the cheapest month on offer anywhere, which is a different question, with a different answer.

What else do people ask about dose pricing?

• Does a GLP-1 price normally go up as the dose goes up?It depends entirely on the company, and both models are common here. 83 of the 412 companies published on this site say somewhere in their own material that the price is the same at every dose; 47 say the opposite, that the price follows the dose. Every one of those 130 companies is named here with the sentence it was classified on, as of August 31, 2026.
• What is the biggest price difference between a low dose and a high one?VitaStir, whose published rungs for compounded tirzepatide run from $145 at 2.5 mg to $599 at 15 mg: 4.13 times the entry figure, on one company's own published table.
• Do any of these promises have conditions attached?1 of the 83 publish an exclusion beside the promise. Eden's policy covers dosage adjustments while excluding new-member promotions. Amble's disclosure says the claim "expires within 24 hours of any price updates" and that introductory and first-month offers "are not governed by the 'same price per dose' policy". Both date from August 31, 2026 and both are quoted in full below.
• Is a flat price better than a dose ladder?Not automatically. A flat price is easier to budget and it is a real commitment where the terms carry no exclusion. A published dose ladder is worse to budget and better to verify, because you can see exactly what the next step costs before you take it. The worst combination is neither: a company that neither promises a flat price nor publishes the tiers, which this roster also contains.

Sources

Every sentence below comes from the company's own domain, or from a screen inside its intake, on August 31, 2026, and is quoted verbatim.

How the sets are built: a company is counted under The promise when its own material says the price does not change with the dose, under The ladder that climbs when its own material says it does, and under The exclusion attached to it when it publishes a condition on the promise. Each row above carries the sentence the classification was made on. Companies saying nothing either way on the pages recorded in their reviews are counted in neither, which is why the two sets do not add up to 412.

Nothing here is clinical advice, and none of it says which dose anybody should be on. This site has no clinician on its masthead and never invents one. What a dose does to a price is the only question here. Companies named as promising a flat price are quoted 5 times in the table above; companies named as pricing by dose, 6.

Some companies named here pay us a commission when a reader starts care through a marked link. The one marked link on this page is one of them, picked by rule and disclosed beside it. Nothing above is ordered by who pays: the spread table is ordered by the size of the multiple, which you can re-derive from each review's ladder. Who pays us · how we review · every review.